UnitedHealth (UNH) Stock Surges on Improved 2027 Medicare Advantage Payment Rate

Key Highlights

• UnitedHealth shares gained 1.5% Monday, reaching an intraday high of $283.30 and settling at $281.46.
• CMS revealed its final 2027 Medicare Advantage payment rate of 2.48%, substantially higher than the preliminary 0.09% figure announced in January.
• The rate adjustment will deliver an extra $13 billion in federal payments to health insurers in the coming year.
• Raymond James elevated UNH to “outperform” from “market perform” before the company’s Q1 earnings release scheduled for April 21, establishing a $330 target price.
• Humana stock soared 11% in premarket hours following the Medicare announcement; both UNH and CVS Health climbed over 6% before market opening.

UNH began Monday’s session at $277.26, peaked at $283.30, and concluded trading at $281.46 — representing a 1.5% advance.

UnitedHealth Group Incorporated, UNH

The healthcare giant’s shares have declined approximately 22% during the past six months and currently trade beneath both the 50-day moving average of $283.03 and the 200-day moving average of $319.62. Analysts maintain a consensus target price of $363.38.

Following the market close on Monday, the Centers for Medicare and Medicaid Services (CMS) unveiled its final payment rate for 2027 Medicare Advantage programs. The announcement revealed a 2.48% average rate increase — a substantial improvement over the 0.09% preliminary rate proposed in January that had shaken investor confidence across the health insurance sector.

The initial January proposal triggered declines in both UNH and Humana when disclosed. Financial analysts had been monitoring developments closely, anticipating potential revisions in the final determination.

The upgraded rate will inject $13 billion in incremental government payments to health insurers during the next year. UNH and CVS Health, Aetna’s parent company, experienced premarket surges exceeding 6% after the disclosure. Humana’s shares jumped 11%.

Why Medicare Advantage Matters to the Bottom Line

Medicare Advantage represents the private-sector alternative to conventional Medicare and currently serves approximately 35 million enrollees this year, based on data from KFF, a health policy research organization. Participation has expanded consistently and now surpasses traditional Medicare enrollment.

For major insurers like UnitedHealth, Medicare Advantage constitutes a critical revenue stream. An essentially flat rate adjustment — while medical expenses are climbing 7% to 9% annually — would have functioned as a de facto reduction, according to analysis from the Better Medicare Alliance.

TD Cowen analyst Ryan Langston had anticipated a more conservative increase between 1% and 1.5%, making the final announcement exceed certain projections.

Bipartisan political pressure has complicated the rate environment. Lawmakers from both major parties have expressed concerns regarding insurers receiving elevated payments through diagnostic coding practices — commonly referred to as risk adjustment. The Biden administration implemented stricter regulations, and the Trump administration’s January preliminary proposal indicated ongoing regulatory attention.

First Quarter Earnings Expected April 21

Raymond James upgraded UNH from “market perform” to “outperform” on April 1, establishing a $330 price objective. The investment firm pointed to opportunities for management to demonstrate operational stability heading into the earnings announcement.

Barclays maintains an “overweight” recommendation with a $327 target. Both Mizuho and Leerink Partners assign “outperform” ratings, with price targets of $350 and $345 respectively.

Among 28 analysts following UNH, 18 assign Buy ratings, seven recommend Hold, and two rate it Sell. MarketBeat’s aggregated consensus is Moderate Buy.

First quarter financial results are scheduled for release on April 21. During Q4, UNH reported earnings per share of $2.11, surpassing the consensus forecast of $2.09. Revenue reached $113.73 billion, reflecting 12.3% year-over-year growth. Management has issued fiscal 2026 EPS guidance of $17.75.

UNH distributes a quarterly dividend of $2.21 per share, equating to a 3.1% annualized yield at current valuation levels.

Institutional investors hold 87.86% of outstanding shares, with recent position increases from Norges Bank, Berkshire Hathaway, and T. Rowe Price.

The post UnitedHealth (UNH) Stock Surges on Improved 2027 Medicare Advantage Payment Rate appeared first on Blockonomi.